Report Overview
Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.
This report provides a deep insight into the global Neurological Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurological Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurological Drugs market in any manner.
Global Neurological Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
North China Pharmaceutical
Harbin Pharmaceutical Co., Ltd.
Lukang Pharmaceutical
Kelun Pharmaceutical
Kehua Biology
Market Segmentation (by Type)
Non-prescription drugs
Prescription
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Neurological Drugs Market
? Overview of the regional outlook of the Neurological Drugs Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurological Drugs
1.2 Key Market Segments
1.2.1 Neurological Drugs Segment by Type
1.2.2 Neurological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurological Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Neurological Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurological Drugs Market Competitive Landscape
3.1 Global Neurological Drugs Sales by Manufacturers (2019-2024)
3.2 Global Neurological Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Drugs Sales Sites, Area Served, Product Type
3.6 Neurological Drugs Market Competitive Situation and Trends
3.6.1 Neurological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurological Drugs Industry Chain Analysis
4.1 Neurological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurological Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurological Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Drugs Sales Market Share by Type (2019-2024)
6.3 Global Neurological Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Drugs Price by Type (2019-2024)
7 Neurological Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Drugs Market Sales by Application (2019-2024)
7.3 Global Neurological Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Drugs Sales Growth Rate by Application (2019-2024)
8 Neurological Drugs Market Segmentation by Region
8.1 Global Neurological Drugs Sales by Region
8.1.1 Global Neurological Drugs Sales by Region
8.1.2 Global Neurological Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Neurological Drugs Basic Information
9.1.2 Pfizer Neurological Drugs Product Overview
9.1.3 Pfizer Neurological Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Neurological Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Ely Lilly
9.2.1 Ely Lilly Neurological Drugs Basic Information
9.2.2 Ely Lilly Neurological Drugs Product Overview
9.2.3 Ely Lilly Neurological Drugs Product Market Performance
9.2.4 Ely Lilly Business Overview
9.2.5 Ely Lilly Neurological Drugs SWOT Analysis
9.2.6 Ely Lilly Recent Developments
9.3 Actavis
9.3.1 Actavis Neurological Drugs Basic Information
9.3.2 Actavis Neurological Drugs Product Overview
9.3.3 Actavis Neurological Drugs Product Market Performance
9.3.4 Actavis Neurological Drugs SWOT Analysis
9.3.5 Actavis Business Overview
9.3.6 Actavis Recent Developments
9.4 Mylan
9.4.1 Mylan Neurological Drugs Basic Information
9.4.2 Mylan Neurological Drugs Product Overview
9.4.3 Mylan Neurological Drugs Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 Randox
9.5.1 Randox Neurological Drugs Basic Information
9.5.2 Randox Neurological Drugs Product Overview
9.5.3 Randox Neurological Drugs Product Market Performance
9.5.4 Randox Business Overview
9.5.5 Randox Recent Developments
9.6 Intellipharmaceutics
9.6.1 Intellipharmaceutics Neurological Drugs Basic Information
9.6.2 Intellipharmaceutics Neurological Drugs Product Overview
9.6.3 Intellipharmaceutics Neurological Drugs Product Market Performance
9.6.4 Intellipharmaceutics Business Overview
9.6.5 Intellipharmaceutics Recent Developments
9.7 Astrazeneca
9.7.1 Astrazeneca Neurological Drugs Basic Information
9.7.2 Astrazeneca Neurological Drugs Product Overview
9.7.3 Astrazeneca Neurological Drugs Product Market Performance
9.7.4 Astrazeneca Business Overview
9.7.5 Astrazeneca Recent Developments
9.8 Lundbeck
9.8.1 Lundbeck Neurological Drugs Basic Information
9.8.2 Lundbeck Neurological Drugs Product Overview
9.8.3 Lundbeck Neurological Drugs Product Market Performance
9.8.4 Lundbeck Business Overview
9.8.5 Lundbeck Recent Developments
9.9 Allergan
9.9.1 Allergan Neurological Drugs Basic Information
9.9.2 Allergan Neurological Drugs Product Overview
9.9.3 Allergan Neurological Drugs Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 GSK
9.10.1 GSK Neurological Drugs Basic Information
9.10.2 GSK Neurological Drugs Product Overview
9.10.3 GSK Neurological Drugs Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Otsuka Pharmaceutical
9.11.1 Otsuka Pharmaceutical Neurological Drugs Basic Information
9.11.2 Otsuka Pharmaceutical Neurological Drugs Product Overview
9.11.3 Otsuka Pharmaceutical Neurological Drugs Product Market Performance
9.11.4 Otsuka Pharmaceutical Business Overview
9.11.5 Otsuka Pharmaceutical Recent Developments
9.12 Takeda
9.12.1 Takeda Neurological Drugs Basic Information
9.12.2 Takeda Neurological Drugs Product Overview
9.12.3 Takeda Neurological Drugs Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 NHU Group
9.13.1 NHU Group Neurological Drugs Basic Information
9.13.2 NHU Group Neurological Drugs Product Overview
9.13.3 NHU Group Neurological Drugs Product Market Performance
9.13.4 NHU Group Business Overview
9.13.5 NHU Group Recent Developments
9.14 Shionogi
9.14.1 Shionogi Neurological Drugs Basic Information
9.14.2 Shionogi Neurological Drugs Product Overview
9.14.3 Shionogi Neurological Drugs Product Market Performance
9.14.4 Shionogi Business Overview
9.14.5 Shionogi Recent Developments
9.15 APOTEX
9.15.1 APOTEX Neurological Drugs Basic Information
9.15.2 APOTEX Neurological Drugs Product Overview
9.15.3 APOTEX Neurological Drugs Product Market Performance
9.15.4 APOTEX Business Overview
9.15.5 APOTEX Recent Developments
9.16 North China Pharmaceutical
9.16.1 North China Pharmaceutical Neurological Drugs Basic Information
9.16.2 North China Pharmaceutical Neurological Drugs Product Overview
9.16.3 North China Pharmaceutical Neurological Drugs Product Market Performance
9.16.4 North China Pharmaceutical Business Overview
9.16.5 North China Pharmaceutical Recent Developments
9.17 Harbin Pharmaceutical Co., Ltd.
9.17.1 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Basic Information
9.17.2 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Overview
9.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Market Performance
9.17.4 Harbin Pharmaceutical Co., Ltd. Business Overview
9.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments
9.18 Lukang Pharmaceutical
9.18.1 Lukang Pharmaceutical Neurological Drugs Basic Information
9.18.2 Lukang Pharmaceutical Neurological Drugs Product Overview
9.18.3 Lukang Pharmaceutical Neurological Drugs Product Market Performance
9.18.4 Lukang Pharmaceutical Business Overview
9.18.5 Lukang Pharmaceutical Recent Developments
9.19 Kelun Pharmaceutical
9.19.1 Kelun Pharmaceutical Neurological Drugs Basic Information
9.19.2 Kelun Pharmaceutical Neurological Drugs Product Overview
9.19.3 Kelun Pharmaceutical Neurological Drugs Product Market Performance
9.19.4 Kelun Pharmaceutical Business Overview
9.19.5 Kelun Pharmaceutical Recent Developments
9.20 Kehua Biology
9.20.1 Kehua Biology Neurological Drugs Basic Information
9.20.2 Kehua Biology Neurological Drugs Product Overview
9.20.3 Kehua Biology Neurological Drugs Product Market Performance
9.20.4 Kehua Biology Business Overview
9.20.5 Kehua Biology Recent Developments
10 Neurological Drugs Market Forecast by Region
10.1 Global Neurological Drugs Market Size Forecast
10.2 Global Neurological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Drugs Market Size Forecast by Region
10.2.4 South America Neurological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurological Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Drugs by Type (2025-2030)
11.1.2 Global Neurological Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Drugs by Type (2025-2030)
11.2 Global Neurological Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Neurological Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neurological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Neurological Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Neurological Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Neurological Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Neurological Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Drugs as of 2022)
Table 10. Global Market Neurological Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Neurological Drugs Sales Sites and Area Served
Table 12. Manufacturers Neurological Drugs Product Type
Table 13. Global Neurological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Neurological Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neurological Drugs Market Challenges
Table 22. Global Neurological Drugs Sales by Type (Kilotons)
Table 23. Global Neurological Drugs Market Size by Type (M USD)
Table 24. Global Neurological Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Neurological Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Neurological Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Neurological Drugs Market Size Share by Type (2019-2024)
Table 28. Global Neurological Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Neurological Drugs Sales (Kilotons) by Application
Table 30. Global Neurological Drugs Market Size by Application
Table 31. Global Neurological Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Neurological Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Neurological Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Neurological Drugs Market Share by Application (2019-2024)
Table 35. Global Neurological Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Neurological Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Neurological Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Neurological Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Neurological Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Neurological Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Neurological Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Neurological Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Neurological Drugs Basic Information
Table 44. Pfizer Neurological Drugs Product Overview
Table 45. Pfizer Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Neurological Drugs SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Ely Lilly Neurological Drugs Basic Information
Table 50. Ely Lilly Neurological Drugs Product Overview
Table 51. Ely Lilly Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ely Lilly Business Overview
Table 53. Ely Lilly Neurological Drugs SWOT Analysis
Table 54. Ely Lilly Recent Developments
Table 55. Actavis Neurological Drugs Basic Information
Table 56. Actavis Neurological Drugs Product Overview
Table 57. Actavis Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Actavis Neurological Drugs SWOT Analysis
Table 59. Actavis Business Overview
Table 60. Actavis Recent Developments
Table 61. Mylan Neurological Drugs Basic Information
Table 62. Mylan Neurological Drugs Product Overview
Table 63. Mylan Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mylan Business Overview
Table 65. Mylan Recent Developments
Table 66. Randox Neurological Drugs Basic Information
Table 67. Randox Neurological Drugs Product Overview
Table 68. Randox Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Randox Business Overview
Table 70. Randox Recent Developments
Table 71. Intellipharmaceutics Neurological Drugs Basic Information
Table 72. Intellipharmaceutics Neurological Drugs Product Overview
Table 73. Intellipharmaceutics Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Intellipharmaceutics Business Overview
Table 75. Intellipharmaceutics Recent Developments
Table 76. Astrazeneca Neurological Drugs Basic Information
Table 77. Astrazeneca Neurological Drugs Product Overview
Table 78. Astrazeneca Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Astrazeneca Business Overview
Table 80. Astrazeneca Recent Developments
Table 81. Lundbeck Neurological Drugs Basic Information
Table 82. Lundbeck Neurological Drugs Product Overview
Table 83. Lundbeck Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lundbeck Business Overview
Table 85. Lundbeck Recent Developments
Table 86. Allergan Neurological Drugs Basic Information
Table 87. Allergan Neurological Drugs Product Overview
Table 88. Allergan Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Allergan Business Overview
Table 90. Allergan Recent Developments
Table 91. GSK Neurological Drugs Basic Information
Table 92. GSK Neurological Drugs Product Overview
Table 93. GSK Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. GSK Business Overview
Table 95. GSK Recent Developments
Table 96. Otsuka Pharmaceutical Neurological Drugs Basic Information
Table 97. Otsuka Pharmaceutical Neurological Drugs Product Overview
Table 98. Otsuka Pharmaceutical Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Otsuka Pharmaceutical Business Overview
Table 100. Otsuka Pharmaceutical Recent Developments
Table 101. Takeda Neurological Drugs Basic Information
Table 102. Takeda Neurological Drugs Product Overview
Table 103. Takeda Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Takeda Business Overview
Table 105. Takeda Recent Developments
Table 106. NHU Group Neurological Drugs Basic Information
Table 107. NHU Group Neurological Drugs Product Overview
Table 108. NHU Group Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. NHU Group Business Overview
Table 110. NHU Group Recent Developments
Table 111. Shionogi Neurological Drugs Basic Information
Table 112. Shionogi Neurological Drugs Product Overview
Table 113. Shionogi Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Shionogi Business Overview
Table 115. Shionogi Recent Developments
Table 116. APOTEX Neurological Drugs Basic Information
Table 117. APOTEX Neurological Drugs Product Overview
Table 118. APOTEX Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. APOTEX Business Overview
Table 120. APOTEX Recent Developments
Table 121. North China Pharmaceutical Neurological Drugs Basic Information
Table 122. North China Pharmaceutical Neurological Drugs Product Overview
Table 123. North China Pharmaceutical Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. North China Pharmaceutical Business Overview
Table 125. North China Pharmaceutical Recent Developments
Table 126. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Basic Information
Table 127. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Overview
Table 128. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Harbin Pharmaceutical Co., Ltd. Business Overview
Table 130. Harbin Pharmaceutical Co., Ltd. Recent Developments
Table 131. Lukang Pharmaceutical Neurological Drugs Basic Information
Table 132. Lukang Pharmaceutical Neurological Drugs Product Overview
Table 133. Lukang Pharmaceutical Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Lukang Pharmaceutical Business Overview
Table 135. Lukang Pharmaceutical Recent Developments
Table 136. Kelun Pharmaceutical Neurological Drugs Basic Information
Table 137. Kelun Pharmaceutical Neurological Drugs Product Overview
Table 138. Kelun Pharmaceutical Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Kelun Pharmaceutical Business Overview
Table 140. Kelun Pharmaceutical Recent Developments
Table 141. Kehua Biology Neurological Drugs Basic Information
Table 142. Kehua Biology Neurological Drugs Product Overview
Table 143. Kehua Biology Neurological Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Kehua Biology Business Overview
Table 145. Kehua Biology Recent Developments
Table 146. Global Neurological Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Neurological Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Neurological Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Neurological Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Neurological Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Neurological Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Neurological Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Neurological Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Neurological Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Neurological Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Neurological Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Neurological Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Neurological Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Neurological Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Neurological Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Neurological Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Neurological Drugs Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Neurological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neurological Drugs Market Size (M USD), 2019-2030
Figure 5. Global Neurological Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Neurological Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neurological Drugs Market Size by Country (M USD)
Figure 11. Neurological Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Neurological Drugs Revenue Share by Manufacturers in 2023
Figure 13. Neurological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Neurological Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Neurological Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Neurological Drugs Market Share by Type
Figure 18. Sales Market Share of Neurological Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Neurological Drugs by Type in 2023
Figure 20. Market Size Share of Neurological Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Neurological Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Neurological Drugs Market Share by Application
Figure 24. Global Neurological Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Neurological Drugs Sales Market Share by Application in 2023
Figure 26. Global Neurological Drugs Market Share by Application (2019-2024)
Figure 27. Global Neurological Drugs Market Share by Application in 2023
Figure 28. Global Neurological Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Neurological Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Neurological Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Neurological Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Neurological Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Neurological Drugs Sales Market Share by Country in 2023
Figure 37. Germany Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Neurological Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Neurological Drugs Sales Market Share by Region in 2023
Figure 44. China Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Neurological Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Neurological Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Neurological Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Neurological Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Neurological Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Neurological Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Neurological Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Neurological Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Neurological Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Neurological Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Neurological Drugs Market Share Forecast by Application (2025-2030)
